Q: Patients with hypokalemic Periodic Paralysis (HPP) usually have? - select one
A) Calcium channel disorders
B) Potassium channel disorders
C) Sodium channel disorders
Answer: A
Although HPP is a potassium-related pathophysiology, as the name suggests, the most common underlying gene mutation is a calcium channel disorder, involving the gene that codes for the alpha-1 subunit of the dihydropyridine-sensitive calcium channel in skeletal muscle.
The mechanism by which the calcium channel defect leads to episodic potassium influx into cells is not fully understood. The proposed mechanism, along with a few others, is that a gene disorder causes a decreased calcium current density and slower rate of activation.
There could also be a pathology involving insulin sensitivity or hyperthyroidism.
Some patients may also have sodium channel disorders with a mutation in the skeletal muscle sodium channel, SCN4A, but this is uncommon. It affects males and females equally, in contrast to calcium channel disorders, which affect mostly males.
Some patients may not have either of the above channel disorders but may have other potentially associated mutations.
#electrolytes
#musculoskeletal
References:
1. Ptácek LJ, Tawil R, Griggs RC, et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 1994; 77:863.
2. Matthews E, Labrum R, Sweeney MG, et al. Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology 2009; 72:1544.
3. Ruff RL. Insulin acts in hypokalemic periodic paralysis by reducing inward rectifier K+ current. Neurology 1999; 53:1556.
4. Sternberg D, Maisonobe T, Jurkat-Rott K, et al. Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain 2001; 124:1091.